These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34781115)

  • 1. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
    Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
    Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of 5-Fluorouracil and gemcitabine hydrochloride loaded iron‑based chitosan-coated MIL-100 composite as an advanced, biocompatible, pH-sensitive and smart drug delivery system on breast cancer therapy.
    Resen AK; Atiroğlu A; Atiroğlu V; Guney Eskiler G; Aziz IH; Kaleli S; Özacar M
    Int J Biol Macromol; 2022 Feb; 198():175-186. PubMed ID: 34973989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of potent biocompatible metal-organic framework for efficient encapsulation and delivery of Gemcitabine: biodistribution, pharmacokinetic and cytotoxicity study.
    Kush P; Kaur M; Sharma M; Madan J; Kumar P; Deep A; Kim KH
    Biomed Phys Eng Express; 2020 Feb; 6(2):025014. PubMed ID: 33438640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-loaded gold nanospheres mediated by albumin for enhanced anti-tumor activity combining with CT imaging.
    Wang Z; Chen L; Chu Z; Huang C; Huang Y; Jia N
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():106-118. PubMed ID: 29752079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
    Parsian M; Mutlu P; Yalcin S; Gunduz U
    Anticancer Agents Med Chem; 2020; 20(10):1233-1240. PubMed ID: 32156242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protein-sulfosalicylic acid/boswellic acids @metal-organic framework nanocomposite as anticancer drug delivery system.
    Özsoy M; Atiroğlu V; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111788. PubMed ID: 33932885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
    Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
    ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
    Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
    Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
    Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.
    Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS
    Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells.
    Umar S; Samokhvalov A
    Molecules; 2024 Jul; 29(13):. PubMed ID: 38999141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio.
    Das M; Jain R; Agrawal AK; Thanki K; Jain S
    Bioconjug Chem; 2014 Mar; 25(3):501-9. PubMed ID: 24506698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.
    Kushwah V; Agrawal AK; Dora CP; Mallinson D; Lamprou DA; Gupta RC; Jain S
    Pharm Res; 2017 Nov; 34(11):2295-2311. PubMed ID: 28795274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy.
    Han H; Valdepérez D; Jin Q; Yang B; Li Z; Wu Y; Pelaz B; Parak WJ; Ji J
    ACS Nano; 2017 Feb; 11(2):1281-1291. PubMed ID: 28071891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
    Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
    Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging.
    Shu F; Lv D; Song XL; Huang B; Wang C; Yu Y; Zhao SC
    RSC Adv; 2018 Feb; 8(12):6581-6589. PubMed ID: 35540394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biocompatible metal-organic framework as a pH and temperature dual-responsive drug carrier.
    Lin W; Cui Y; Yang Y; Hu Q; Qian G
    Dalton Trans; 2018 Nov; 47(44):15882-15887. PubMed ID: 30362496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach.
    Kandagal PB; Ashoka S; Seetharamappa J; Shaikh SM; Jadegoud Y; Ijare OB
    J Pharm Biomed Anal; 2006 May; 41(2):393-9. PubMed ID: 16413740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled drug release from polyelectrolyte-drug conjugate nanoparticles.
    Catarata R; Azim N; Bhattacharya S; Zhai L
    J Mater Chem B; 2020 Apr; 8(14):2887-2894. PubMed ID: 32191246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.